Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

Clinical trial NCT07670468 · RECRUITING

Trial details

NCT number: NCT07670468
Sponsor: LucasBio
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

BKV Infection EBV Infection CMV Infection

Start date: 2025-12-04
Primary completion: 2027-06-04
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.